Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.84B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.48B |
| 3 |
Nike
NKE
|
+$1.17B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$922M |
| 5 |
Hewlett Packard
HPE
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$1.14B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.13B |
| 3 |
Broadcom
AVGO
|
+$625M |
| 4 |
UnitedHealth
UNH
|
+$584M |
| 5 |
Mastercard
MA
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.22% |
| 2 | Financials | 9.75% |
| 3 | Consumer Discretionary | 7.43% |
| 4 | Healthcare | 7.41% |
| 5 | Industrials | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4876
Caribou Biosciences
CRBU
$162M
| $751K | ﹤0.01% |
822,840
-247,696
| -23% | -$322K |
|
4877
PUT
Warner Bros
WBD
$66.9B
| $751K | ﹤0.01% |
70,000
-50,000
| -42% | -$523K |
|
|
VTLE
4878
CALL
DELISTED
Vital Energy
VTLE
| $747K | ﹤0.01% |
35,200
| – | – |
|
|
VTLE
4879
PUT
DELISTED
Vital Energy
VTLE
| $747K | ﹤0.01% |
35,200
| – | – |
|
4880
Idaho Strategic Resources
IDR
$544M
| $746K | ﹤0.01% |
52,099
+9,298
| +22% | +$114K |
|
|
FLNA
4881
Filana Therapeutics
FLNA
$46.7M
| $744K | ﹤0.01% |
496,313
+217,404
| +78% | +$549K |
|
4882
Black Diamond Therapeutics
BDTX
$110M
| $743K | ﹤0.01% |
479,387
-4,449
| -0.9% | -$9.33K |
|
4883
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
$1.1B
| $742K | ﹤0.01% |
10,599
| – | – |
|
4884
Protalix BioTherapeutics
PLX
$198M
| $741K | ﹤0.01% |
289,461
+239,751
| +482% | +$573K |
|
|
CVAC
4885
DELISTED
CureVac
CVAC
| $741K | ﹤0.01% |
267,404
-75,941
| -22% | -$264K |
|
4886
iShares U.S. Large Cap Premium Income Active ETF
BALI
$1.35B
| $737K | ﹤0.01% |
+25,587
| New | +$771K |
|
4887
WisdomTree US SmallCap Earnings Fund
EES
$733M
| $734K | ﹤0.01% |
15,029
| – | – |
|
4888
American Outdoor Brands
AOUT
$160M
| $731K | ﹤0.01% |
60,110
+22,232
| +59% | +$341K |
|
4889
Standard BioTools
LAB
$315M
| $731K | ﹤0.01% |
676,529
-496,941
| -42% | -$698K |
|
4890
Ponce Financial Group
PDLB
$485M
| $728K | ﹤0.01% |
57,455
-17,803
| -24% | -$233K |
|
4891
West Bancorporation
WTBA
$482M
| $728K | ﹤0.01% |
36,494
-10,411
| -22% | -$222K |
|
4892
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$551M
| $728K | ﹤0.01% |
8,887
-29,747
| -77% | -$2.4M |
|
|
SRTA
4893
Strata Critical Medical Inc
SRTA
$518M
| $727K | ﹤0.01% |
266,414
-106,618
| -29% | -$382K |
|
4894
PUT
Prologis
PLD
$133B
| $727K | ﹤0.01% |
6,500
-1,700
| -21% | -$197K |
|
4895
iShares MSCI Ireland ETF
EIRL
$78.4M
| $726K | ﹤0.01% |
12,276
-2,978
| -20% | -$179K |
|
4896
Zentalis Pharmaceuticals
ZNTL
$300M
| $726K | ﹤0.01% |
456,393
-461,714
| -50% | -$996K |
|
4897
Tyra Biosciences
TYRA
$1.57B
| $725K | ﹤0.01% |
78,006
+13,896
| +22% | +$180K |
|
4898
Greif Class B
GEF.B
$4.23B
| $725K | ﹤0.01% |
12,233
-6,718
| -35% | -$416K |
|
4899
Evolution Petroleum
EPM
$131M
| $724K | ﹤0.01% |
139,715
+27,068
| +24% | +$141K |
|
4900
Enanta Pharmaceuticals
ENTA
$395M
| $720K | ﹤0.01% |
130,410
+6,549
| +5% | +$40.5K |
|
Similar funds
Goldman Sachs's Q1 2025 Portfolio in Review
As of Q1 2025, Goldman Sachs held 6,539 positions worth $618B, down 2.6% from $634B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs's Q1 2025 filing shows 547 new, 2,373 increased, 2,724 reduced and 514 closed positions. Its largest new stake was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M. The largest sale was TC Energy, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q1 2025 buy was Fidelity Enhanced Large Cap Core ETF: 2,339,740 shares worth $73M.
- Goldman Sachs added most to iShares Russell 2000 ETF in Q1 2025, an estimated $1.84B increase.
- Goldman Sachs's biggest Q1 2025 reduction was TC Energy, cutting an estimated $1.14B.
- Goldman Sachs fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $242M.
- Goldman Sachs's ten largest holdings make up 20% of its $618B portfolio in Q1 2025.
- Goldman Sachs opened 547 new positions and closed 514 in Q1 2025.
- Goldman Sachs's portfolio value fell 2.6% quarter-over-quarter to $618B.
Based on Goldman Sachs's 13F filing for Q1 2025, filed 9 May 2025.